Feature | July 15, 2011| Mladen I. Vidovich, M.D., FACC, FSCAI

EuroPCR: Radial PCI Lowers STEMI Mortality at 30 Days and One Year

Swedish SCAAR Registry data were presented in May during the EuroPCR meeting in Paris. The 30-day ST-elevated myocardial infarction (STEMI) mortality was 4.4% in the femoral access group vs. 3.2% in the radial access group (adjusted odds ratio 0.57, p<0.01). The benefit of radial approach was present at one year as well (7.3% femoral vs. 6.2% radial mortality, adjusted OR 0.78, p=0.018).

These are contemporary data from 2005-2010, during which use of radial increased from 12 to 50%, while the use of bivalirudin increased and use of GP 2B/3A inhibitors decreased. The serious bleeding events occurred in 2.2% of patients in the femoral group and 1% in the radial group. Nonetheless, despite the well-recognized limitations present in a retrospective registry analysis, these findings are in line with the subgroup analysis from the RIVAL study. The SCAAR registry data certainly adds to the growing evidence supporting radial approach in high-risk PCI.

Related Content

ThinkRadial, Merit Medical Systems, Vascular Training Model

2015 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) attendees demo the ThinkRadial Vascular Training Model. Image courtesy of Merit Medical Systems Inc.

News | Radial Access| November 17, 2015
Merit Medical Systems Inc. and its ThinkRadial education program now offers a new vascular training model at events...
Sponsored Content | Videos | Radial Access| October 30, 2015
Sunil Rao, M.D., associate professor of medicine and a member in the Duke University Clinical Research Institute, a l
transradial access, TRI, DRAGON trial, TCT 2015, non-inferiority, transfemoral access, TFO
Feature | Radial Access| October 18, 2015
Results from a prospective randomized trial of transradial (TRI) versus transfemoral (TFO) access in patients...
ESC guidelines, radial approach, percutaneous coronary intervention, PCI, acute coronary syndrome, ACS
News | Radial Access| September 18, 2015
For the first time, European Society of Cardiology (ESC) guidelines give the highest degree of recommendation for the...
News | Cath Lab| August 26, 2015
August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report in
Feature | March 24, 2015
atients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not...
News | October 27, 2014
Merit Medical Systems Inc. recently unveil its new ThinkRadial website and educational initiative at thinkradial.com.
News | April 21, 2014
Treatment options for high-risk heart patients with severely calcified coronary artery disease (CAD) have been limited...
cath lab radial access SCAI
Feature | November 13, 2013
The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best...
Overlay Init